Signaling Pathways
-
B6546 E4CPGSummary: group I/group II metabotropic glutamate receptor antagonist -
B6548 RS 16566 dihydrochlorideSummary: ligand for the (R)-zacopride binding site -
B6550 LY 225910Summary: CCK2 receptor antagonist -
B6551 LY 235959Summary: NMDA receptor antagonist -
B6552 CGP 20712 dihydrochlorideTarget: adrenoceptorSummary: β1 antagonist,highly potent and selective -
B6553 Nisoxetine hydrochlorideSummary: noradrenalin uptake inhibitor -
B6554 PHCCCSummary: Group I metabotropic glutamate receptor antagonist -
B6555 CPCCOEtSummary: hmGlu1 subtype-selective antagonist -
B6556 Methyllycaconitine citrateSummary: α7-containing neuronal nicotinic receptors antagonist -
B6557 Piribedil dihydrochlorideSummary: dopamine agonist

